FDA Orange Book
Is there a generic for Durysta?
Durysta contains bimatoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Durysta (bimatoprost). The Orange Book shows its last listed patent expires October 31, 2034.
Run it in Rivvi
Map Durysta and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Durysta products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| implant, ophthalmic | 10MCG | Marketed (Rx) | None | 0 | None |
NDA 211911, held by ABBVIE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Durysta patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10441543 | December 19, 2026 | Drug product | None | 211911 |
| 9149428 | December 19, 2026 | Drug product | None | 211911 |
| 8206737 | April 7, 2027 | Method of use | U-2759 | 211911 |
| 7799336 | April 24, 2029 | Drug product | None | 211911 |
| 8629185 | July 15, 2031 | Drug substance, Drug product | None | 211911 |
| 9980974 | October 31, 2034 | Method of use | U-2759 | 211911 |
| 9492316 | October 31, 2034 | Drug product | None | 211911 |
Durysta NDC codes
Questions
Is there a generic for Durysta?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Durysta (bimatoprost). The Orange Book shows its last listed patent expires October 31, 2034.
What is the generic name for Durysta?
The active ingredient in Durysta is bimatoprost, per the FDA Orange Book.
When does the Durysta patent expire?
The last patent listed for Durysta in the Orange Book expires October 31, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Durysta and Bimatoprost
- What is Bimatoprost used for?FDA label uses
- Is Bimatoprost a controlled substance?Federal schedule
- Generic for ZolymbusFDA Orange Book
- Generic for LumiganFDA Orange Book
- Generic for LatisseFDA Orange Book
- Prostaglandin Analogs listFDA drug class
- Durysta Medicare Part D coverageBy plan and state
- NDC 0023-9652Durysta NDC record